SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-30
👔
AtriCure, Inc.
@ATRC_InsiderForm 4 Filing: Doraiswamy Vinayak Sells $233,280 of $ATRC
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
AtriCure, Inc.
Ticker: $ATRC
Transaction Value
$233,280
Price/Share: $38.88
transaction date
2026-07-28
Shares: 6,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Doraiswamy Vinayak, holds the title of Chief Scientific Officer at AtriCure, Inc..
On 2026-07-28, the insider transacted 6,000 shares.The shares were transacted at a weighted average price of $38.88 per share, resulting in a total market-relevant value of $233,280.
Executive Summary Summary
Doraiswamy Vinayak (Chief Scientific Officer) sold $233K of $ATRC
Post-Transaction Position: 86,511 shares
SEC Accession No: 0001862458-26-000011 (CIK: 1862458)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.